CMS INDUSLAW Advises Hindustan Unilever Limited on Acquisition of Zywie Ventures
CMS INDUSLAW advised Hindustan Unilever Limited (HUL) on its acquisition of the remaining 49% equity shareholding in Zywie Ventures Private Limited (which sells products under the OZiva brand), taking its total stake to 100%, for a cash consideration of INR 8.24 billion.
HUL, one of India’s leading fast-moving consumer goods companies, had previously acquired a 51% stake in Zywie in 2023 as part of its strategic entry into the fast-growing Health & Wellbeing segment. Zywie is a leading plant-based nutrition and wellness brand, offering clean, science-backed products across categories such as women’s health, skin, hair, and general wellbeing. The firm had previously advised HUL on the initial 51% acquisition in Zywie.
Add LawBhoomi as your preferred source on Google.
The CMS INDUSLAW Corporate and IP teams advised HUL on all aspects of the transactions with strategic inputs from Avimukt Dar (Founding & Senior Partner).
Corporate: Shivani Singh (Principal Associate), Rusha Ghosh Dastidar (Associate) and Prakhar Srivastava (Associate)
IP: Bharadwaj Jaishankar (Partner), Trushita Mehra (Senior Associate) and Ishita Goyal (Associate) Past team members also contributed to the transaction during their tenure at CMS INDUSLAW.
Join LawBhoomi’s 100K+ Community
